Deconvolution of clonal dynamics with scTAM-seq
Missionbio
34:52
See how single-cell DNA + DNA methylation + surface protein profiling with scTAM-seq (on Tapestri) dissects treatment response in MDS/AML using sequential patient bone-marrow samples collected during targeted therapy.
- Multi-omic resolution, one assay: scTAM-seq simultaneously profiles somatic mutations, methylation, and protein at single-cell resolution.
- Sharper cell typing: Integrating scTAM-seq + ADT-seq improves cell-type identification, resolving subtle hematopoietic populations.
- Track clonal evolution: Combining scTAM-seq with single-cell genotyping maps clonal architecture and evolution under therapy across sequential samples.
Rethinking response metrics: Understand clinical response that can occur independent of changes in mutant allelic burden, and implications for disease monitoring.
Speaker
Dr Matthieu Duchmann
Assistant Professor in Molecular Hematology, Paris Leukemia Institute
Matthieu Duchmann, MD, PhD, is Assistant Professor in Molecular Hematology at Paris Leukemia Institute, France and Principal Investigator in the Puissant Lab at Inserm. His research focuses on understanding the origin and impact of intratumoral heterogeneity and leukemic cell plasticity in the emergence of treatment resistance in MDS and AML.
Replays
See allDeconvolution of clonal dynamics with scTAM-seq
34:52